2022, ' Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE) : interim analysis of a randomised, controlled, phase 3, immunobridging trial ', The Lancet Infectious Diseases, vol. 22, no. 12, pp. 1716-1727 . https://doi.org/10.1016/S1473-3099(22)00502-3, https://doi.org/10.1016/S1473-3099(22)00502-3
Lazarus, R, Taucher, C, Brown, C, Čorbic Ramljak, I, Danon, L, Dubischar, K, Duncan, C J A, Wright, J K, Kwon, D, Middleditch, A, Penciu, F & Riaz, T & Finn, A 2022, ' Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001 : A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults ', Journal of Infection, vol. 85, no. 3, pp. 306-317 . https://doi.org/10.1016/j.jinf.2022.06.009